Comparison of OS rates among the BCLC-A, SLHCC, and BCLC-B groups stratified by ALBI grade and treatment modality. a ALBI grade 1. b ALBI grade 2. c ALBI grade 3. d Curative treatment. e TACE. f Other treatments. ALBI, albumin-bilirubin; BCLC, Barcelona Clinic Liver Cancer; OS, overall survival; SLHCC, single large hepatocellular carcinoma; TACE, transarterial chemoembolization.